trending Market Intelligence /marketintelligence/en/news-insights/trending/EZJGrZg1Q3F_oNwSiA1C2g2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

UK regulator investigating Concordia's international business segment

COVID-19 Impact & Recovery: Corporations

Blog

COVID-19 Impact & Recovery: Commercial Real estate

Blog

One Year After the COVID Crash: Assessing the Leveraged Loan Market

Blog

COVID-19 Impact & Recovery: Investment Banking


UK regulator investigating Concordia's international business segment

Concordia International Corp. said the U.K. Competition and Markets Authority, or CMA, is investigating the company's international segment as well as certain of its products as part of an inquiry related to the U.K.'s pharmaceutical sector.

The company said that the investigation is at an early, information-gathering stage and the CMA has not reached any conclusions on whether any competition law was infringed.

The company said CMA's investigation includes matters that pre-date Concordia's ownership of Amdipharm Mercury Ltd., the segment in question.